Round Table Discussion on the Lykos FDA Committee Meeting

Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024 – Biotech Investments

Kuros Biosciences AG / Key word(s): Quarter Results 10-Oct-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

October 11, 2024

Q&A: At Flagship’s London outpost, an executive sees scientific potential ready to ‘unlock’

LONDON — A coworking space surrounded by the crush of traffic around King’s Cross station is perhaps not the most glamorous digs. But as the

October 24, 2024

Federal appeals court sides with drugmakers on 340B limitations

A federal appeals court ruled on Tuesday that drugmakers are not restricted from setting contractual limits on the distribution of discounted drugs under a federal

May 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.